BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8453016)

  • 1. Partial rescreening of all negative smears: an improved method of quality assurance in laboratories undertaking cervical screening.
    Faraker CA
    Cytopathology; 1993; 4(1):47-50. PubMed ID: 8453016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural-network-assisted analysis and microscopic rescreening in presumed negative cervical cytologic smears. A comparison.
    Mango LJ; Valente PT
    Acta Cytol; 1998; 42(1):227-32. PubMed ID: 9479345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Partial re-screening of all negative smears. A method of quality control of pathology department concerning smear screening against cervix cancer].
    Jensen ML; Dybdahl H; Svanholm H
    Ugeskr Laeger; 2000 May; 162(21):3024-7. PubMed ID: 10850190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid screening of cervical smears as a method of internal quality control. For how long should we rescreen?
    Farrell DJ; Bilkhu S; Gibson LM; Cummings L; Wadehra V
    Acta Cytol; 1997; 41(2):251-60. PubMed ID: 9100751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid rescreening of cervical smears: an improved method of quality control.
    Dudding N
    Cytopathology; 1995 Apr; 6(2):95-9. PubMed ID: 7795170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
    Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
    Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of partial rescreening as an internal quality control method for cervical smears.
    Johnson SJ; Hair T; Gibson L; Ridley B; Wadehra V
    Cytopathology; 1995 Dec; 6(6):376-87. PubMed ID: 8770539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid review (partial rescreening) of cervical cytology. Four years experience and quality assurance implications.
    Faraker CA; Boxer ME
    J Clin Pathol; 1996 Jul; 49(7):587-91. PubMed ID: 8813961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid review.
    Faraker CA
    Cytopathology; 1998 Apr; 9(2):71-6. PubMed ID: 9660635
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality assurance in cervical smears: 100% rapid rescreening vs. 10% random rescreening.
    Amaral RG; Zeferino LC; Hardy E; Westin MC; Martinez EZ; Montemor EB
    Acta Cytol; 2005; 49(3):244-8. PubMed ID: 15966284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in the routine screening of cervical smears: A study using rapid prescreening and 100% rapid review as internal quality control methods.
    Tavares SB; Alves de Sousa NL; Manrique EJ; Pinheiro de Albuquerque ZB; Zeferino LC; Amaral RG
    Cancer Cytopathol; 2011 Dec; 119(6):367-76. PubMed ID: 21954191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cervical cancer screening. False negative smears].
    Vassilakos P; De Marval F; Muñoz M
    Rev Med Suisse Romande; 1997 Aug; 117(8):597-601. PubMed ID: 9340714
    [No Abstract]   [Full Text] [Related]  

  • 13. The sensitivity of rapid (partial) review of cervical smears.
    Shield PW; Cox NC
    Cytopathology; 1998 Apr; 9(2):84-92. PubMed ID: 9577734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of primary screening by rapid review: 'to act or not to act on the results, that is the question'.
    Slater DN
    Cytopathology; 1998 Apr; 9(2):77-83. PubMed ID: 9577733
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid rescreening.
    Rubin A
    Cytopathology; 1998 Apr; 9(2):141-2. PubMed ID: 9577744
    [No Abstract]   [Full Text] [Related]  

  • 16. Internal quality assurance of sensitivity of primary screening.
    Boxer ME
    Cytopathology; 1998 Oct; 9(5):349-50. PubMed ID: 9800134
    [No Abstract]   [Full Text] [Related]  

  • 17. 100% rapid (partial) rescreening for quality assurance.
    Lemay C; Meisels A
    Acta Cytol; 1999; 43(1):86-8. PubMed ID: 9987456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the 10% rescreen of negative gynecologic smears as a quality assurance measure.
    Tabbara SO; Sidawy MK
    Diagn Cytopathol; 1996 Feb; 14(1):84-6. PubMed ID: 8834084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internal quality assurance in cervical cytology one laboratory's experience.
    Cross PA
    Cytopathology; 1996 Feb; 7(1):25-31. PubMed ID: 8833871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The false-negative fraction: a statistical method to measure the efficacy of cervical smear screening laboratories.
    Dolinar J; Ollayos CW; Tellado M; Ali I; Stevens A; Paquette C; Brodbelt S
    Mil Med; 1999 Jun; 164(6):410-1. PubMed ID: 10377709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.